The expansion of megakaryocyte progenitors from CD34+-enriched mobilized peripheral blood stem cells is inhibited by Flt3-L

被引:6
作者
Case, J
Hicks, C [1 ]
Trickett, A
Kwan, YL
Manoharan, A
机构
[1] St George Hosp, Dept Clin Haematol, Bone Marrow Transplant Unit, Kogarah, NSW 2217, Australia
[2] Univ New S Wales, Sydney, NSW, Australia
关键词
D O I
10.1089/jir.2006.26.76
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study aimed to determine the optimal growth factor combination for expansion of megakaryocyte (Mk) progenitors with clonogenic potential from CD34(+)-enriched mobilized peripheral blood stem cells (PBSC). Mobilized PBSC were monocyte depleted and CD34(+) enriched, then cultured with various combinations of interleukin-3 (IL-3), IL-6, IL-11, Flt3 ligand (Flt3-L), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and erythropoietin (EPO), using a 2(IV)(7-3) fractional factorial design. Expansion of Mk committed progenitors (CD41(+)) and primitive precursors (CD61(+) CD34(+)) was determined using FACS and colony-forming assays. Amplification of Mk progenitor production was attributed to IL-3 (p < 0.002), SCF (p < 0.001), and GM- CSF (p < 0.05). Flt3- L inhibited the production of total CD61(+) cells (p < 0.05), CD61(+) CD34(+) cells (p < 0.03), and total CD41a(+) cells (p < 0.01). Addition of Flt3-L to the optimum growth factor combination of megakaryocyte growth and development factor (MGDF), SCF, IL-3, and GM-CSF caused the greatest increase in total nucleated cells but reduced Mk progenitor expansion. There was also a 20% reduction in Mk (+) colonies from cells expanded in the presence of Flt3- L. Factorial analysis identified the optimal combination of growth factors required to expand Mk precursors with clonogenic potential. The addition of Flt3- L to the optimal combination of MGDF, SCF, IL-3, and GM-CSF reduced both the fold expansion of Mk progenitors and Mk colony numbers.
引用
收藏
页码:76 / 82
页数:7
相关论文
共 30 条
[1]   The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: A controlled trial [J].
Balducci, E ;
Azzarello, G ;
Valenti, MT ;
Capuzzo, GM ;
Pappagallo, GL ;
Pilotti, I ;
Ausoni, S ;
Bari, M ;
Rosetti, F ;
Sartori, D ;
Ciappa, A ;
Porcellini, A ;
Vinante, O .
STEM CELLS, 2003, 21 (01) :33-40
[2]   Modulation of haematopoietic progenitor development by Flt-3 ligand [J].
Banu, N ;
Deng, BJ ;
Lyman, SD ;
Avraham, H .
CYTOKINE, 1999, 11 (09) :679-688
[3]   Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients [J].
Bertolini, F ;
Battaglia, M ;
Pedrazzoli, P ;
DaPrada, GA ;
Lanza, A ;
Soligo, D ;
Caneva, L ;
Sarina, B ;
Murphy, S ;
Thomas, T ;
dellaCuna, GR .
BLOOD, 1997, 89 (08) :2679-2688
[4]  
BRIDDELL RA, 1990, BLOOD, V76, P516
[5]  
BRIDDELL RA, 1992, BLOOD, V79, P332
[6]  
Case J, 2001, CYTOMETRY, V43, P69, DOI 10.1002/1097-0320(20010101)43:1<69::AID-CYTO1020>3.3.CO
[7]  
2-X
[8]  
De Bruyn C, 2003, BLOOD, V102, p421B
[9]   SUBSETS OF CD34(+) CELLS AND RAPID HEMATOPOIETIC RECOVERY AFTER PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION [J].
DERCKSEN, MW ;
RODENHUIS, S ;
DIRKSON, MKA ;
SCHAASBERG, WP ;
BAARS, JW ;
VANDERWALL, E ;
SLAPERCORTENBACH, ICM ;
PINEDO, HM ;
VONDEMBORNE, AEGK ;
VANDERSCHOOT, CE ;
GERRITSEN, WR .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :1922-1932
[10]   Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin [J].
deSauvage, FJ ;
CarverMoore, K ;
Luoh, SM ;
Ryan, A ;
Dowd, M ;
Eaton, DL ;
Moore, MW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) :651-656